<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37249281</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>HIV and inflammatory markers are associated with persistent COVID-19 symptoms.</ArticleTitle><Pagination><StartPage>e859</StartPage><MedlinePgn>e859</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e859</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.859</ELocationID><Abstract><AbstractText Label="BACKGROUND">A proportion of COVID19 survivors may present with long-COVID, which is persistent symptoms lasting four or more weeks post SARS-CoV-2 infection. These symptoms may be mild to severe, and may affect different organ-systems of the body.</AbstractText><AbstractText Label="AIMS">The main objective of this study was to determine the demographic, clinical and immunological factors associated with long COVID.</AbstractText><AbstractText Label="MATERIALS &amp; METHODS">We conducted a nested case control study, with a total of 94 study participants initially included, and 64 participants matched for age and sex for biomarker analyses.</AbstractText><AbstractText Label="RESULTS">32/94 (34.1%) of all the participants had long COVID. Respiratory symptoms were the most common (59.5%) followed by the musculoskeletal symptoms (28.1%). HIV was an independent predictor of long COVID (adjusted odds ratio&#x2009;=&#x2009;2.7; p&#x2009;=&#x2009;.037). In all the 64 matched cases and controls, IFN-&#x3b2; was significantly higher among controls than cases. After stratifying by HIV, IL6 was significantly higher among cases than controls in the HIV- group (2.06 vs. 0.81 pg/mL; p&#x2009;=&#x2009;.02). On the other hand, IFN-&#x3b2; was significantly higher among controls than cases in the HIV+ group (251 vs. 0 pg/mL; p&#x2009;=&#x2009;.01).</AbstractText><AbstractText Label="CONCLUSION">HIV infection is a risk factor for long COVID, and inflammatory markers associated with long COVID may be slightly different for HIV- and HIV+ individuals.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamanzi</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dermatology and Venereology Division, Department of Medicine, University of Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulundu</LastName><ForeName>Gina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology and Microbiology, University of Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mutale</LastName><ForeName>Keagan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>HHV-8 Molecular Virology Laboratory, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mumba</LastName><ForeName>Chibamba</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology and Microbiology, University of Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngalamika</LastName><ForeName>Owen</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-0648-4128</Identifier><AffiliationInfo><Affiliation>Dermatology and Venereology Division, Department of Medicine, University of Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HHV-8 Molecular Virology Laboratory, University Teaching Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K43 TW011095</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 CA221204</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">immunological factors</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37249281</ArticleId><ArticleId IdType="pmc">PMC10165949</ArticleId><ArticleId IdType="doi">10.1002/iid3.859</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoffmann M, Kleine&#x2010;Weber H, Schroeder S, et al. SARS&#x2010;CoV&#x2010;2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2010;280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . WHO Coronavirus (COVID&#x2010;19) Dashboard. WHO; 2022.</Citation></Reference><Reference><Citation>Dadras O, SeyedAlinaghi S, Karimi A, et al. COVID&#x2010;19 mortality and its predictors in the elderly: a systematic review. Health Science Reports. 2022;5(3):e657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9125886</ArticleId><ArticleId IdType="pubmed">35620541</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2010;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . Long COVID or Post&#x2010;COVID Conditions. CDC; 2022.</Citation></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long&#x2010;haul COVID. Nature Immunol. 2022;23(2):194&#x2010;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long&#x2010;coronavirus disease among people living with HIV in western India: an observational study. Immun Inflamm Dis. 2021;9(3):1037&#x2010;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239760</ArticleId><ArticleId IdType="pubmed">34078004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zicari S, Sessa L, Cotugno N, et al. Immune activation, inflammation, and non&#x2010;AIDS co&#x2010;morbidities in HIV&#x2010;infected patients under long&#x2010;term ART. Viruses. 2019;11(3):200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6466530</ArticleId><ArticleId IdType="pubmed">30818749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngalamika O, Lidenge SJ, Mukasine MC, et al. SARS&#x2010;CoV&#x2010;2&#x2010;specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study. Int J Infect Dis. 2023;127:106&#x2010;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9741763</ArticleId><ArticleId IdType="pubmed">36516914</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nat&#xa0;Immunol. 2022;23(2):210&#x2010;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Spinelli MA, Deveau TM, et al. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS&#x2010;COV&#x2010;2 infection. AIDS. 2022;36(12):F7&#x2010;F16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9444925</ArticleId><ArticleId IdType="pubmed">35866847</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Ven NS, Ngalamika O, Martin K, Davies KA, Vera JH. Impact of musculoskeletal symptoms on physical functioning and quality of life among treated people with HIV in high and low resource settings: a case study of the UK and Zambia. PLoS One. 2019;14(5):e0216787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6513081</ArticleId><ArticleId IdType="pubmed">31083692</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non&#x2010;hospitalized adults. Nature Med. 2022;28(8):1706&#x2010;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of post&#x2010;acute lung complications of COVID&#x2010;19. Radiology. 2021;301(2):E383&#x2010;E395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres&#x2010;Castro R, Vasconcello&#x2010;Castillo L, Alsina&#x2010;Restoy X, et al. Respiratory function in patients post&#x2010;infection by COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Pulmonology. 2021;27(4):328&#x2010;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post&#x2010;COVID&#x2010;19 interstitial lung disease. an observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799&#x2010;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>The PHOSP&#x2010;COVID Collaborative Group . Clinical characteristics with inflammation profiling of long COVID and association with 1&#x2010;year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2010;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A, Tahmasebi S, Mahmood A, et al. Th17 and Treg cells function in SARS&#x2010;CoV2 patients compared with healthy controls. J Cell Physiol. 2021;236(4):2829&#x2010;2839.</Citation><ArticleIdList><ArticleId IdType="pubmed">32926425</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckiff BJ, Ram&#xed;rez&#x2010;Su&#xe1;stegui C, Fajardo V, et al. Imbalance of regulatory and cytotoxic SARS&#x2010;CoV&#x2010;2&#x2010;Reactive CD4+&#xa0;T cells in COVID&#x2010;19. Cell. 2020;183(5):1340&#x2010;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534589</ArticleId><ArticleId IdType="pubmed">33096020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolivar S, Anfossi R, Humeres C, et al. IFN&#x2010;beta plays both pro&#x2010; and anti&#x2010;inflammatory roles in the rat cardiac fibroblast through differential STAT protein activation. Front Pharmacol. 2018;9:1368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280699</ArticleId><ArticleId IdType="pubmed">30555324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani MK, Dasmeh P, Fortin A, et al. The combination of IFN &#x3b2; and TNF induces an antiviral and immunoregulatory program via non&#x2010;canonical pathways involving STAT2 and IRF9. Cells. 2019;8(8):919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6721756</ArticleId><ArticleId IdType="pubmed">31426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta&#x2010;1a for disease progression in relapsing multiple sclerosis.&#xa0;The Multiple Sclerosis Collaborative Research Group (MSCRG)\ Ann Neurol. 1996;39(3):285&#x2010;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">8602746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasi M, De Biasi S, Gibellini L, et al. Ageing and inflammation in patients with HIV infection. Clin Exp Immunol. 2017;187(1):44&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5167025</ArticleId><ArticleId IdType="pubmed">27198731</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, ME ; Ipser, JC ; Stein, DJ ; Joska, JA ; Naud&#xe9;, PJW , Peripheral immune dysregulation in the ART era of HIV&#x2010;associated neurocognitive impairments: a systematic review. Psychoneuroendocrinology 2020, 118, 104689.</Citation><ArticleIdList><ArticleId IdType="pubmed">32479968</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>